IP Library › Granted Patent US 12678500
Granted Patent B2
US 12678500 · App. 17/839,940 · Granted Jul 14, 2026

Pathogen destruction system and method using magnetic markers

Inventor: Abron Arrington (Denver, CO)
A61K41/0023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12678500
App. No.
17/839,940
Granted
Jul 14, 2026
Kind
B2
Abstract

A cell destruction method includes providing an anionic biomarker that comprises a magnetic material such as an iron or an iron compound. The anionic biomarker is introduced into an organism having pathogen cells with a negative charge. The anionic biomarkers are attracted to the negative charges of the pathogen and couple thereto. The anionic biomarker may also have a coupler portion that further aids in the anionic biomarker coupling to and being bound to the pathogen cell and/or cell wall. An electric field may be produced to cause the anionic biomarkers and/or the negative charges of the pathogen cell to polarize on or along the pathogen cell. A magnetic field is directed to cause the anionic biomarker, or magnetic material thereof to move and damage the cell. The magnetic field may be an alternating magnetic field that causes the magnetic material to oscillate and damage the cell wall.

Claims (22)

1 . A pathogen cell destruction method comprising:

a) providing an anionic biomarker;

b) providing a magnetic material that is coupled with the biomarker;

c) introducing the biomarker into an organism having a pathogen cell with a negative charge;

d) allowing the anionic biomarker to couple to the pathogen cell;

e) providing a magnetic field generator that produces a magnetic field;

f) directing the magnetic field to cause the magnetic material of the anionic biomarker to move and damage the pathogen cell and thereby destroy the pathogen cell;

g) providing an electric field generator; and

h) producing an electric field to polarize the pathogen cell;

wherein the anionic biomarker further comprises a coupler portion that is configured to couple with the pathogen cell

wherein the magnetic field generator generates an alternating magnetic field; and

wherein the magnetic material is physically bound to the anionic biomarker.

2 . The pathogen cell destruction method of claim 1 , wherein the magnetic material coupled with the anionic biomarker comprises iron.

3 . The pathogen cell destruction method of claim 2 , wherein the magnetic material coupled with the anionic biomarker comprises nanoparticles of said iron.

4 . The pathogen cell destruction method of claim 1 , wherein the anionic biomarker comprises a ferromagnetic metal.

5 . The pathogen cell destruction method of claim 4 , wherein the anionic biomarker comprises nanoparticles of said ferromagnetic metal.

6 . The pathogen cell destruction method of claim 1 , wherein the magnetic material is chemically bound to the anionic biomarker.

7 . The pathogen cell destruction method of claim 1 , wherein the electric field is generated before the anionic biomarker is coupled to the pathogen cell.

8 . The pathogen cell destruction method of claim 1 , wherein the electric field is generated before the magnetic field is produced.

9 . The pathogen cell destruction method of claim 1 , wherein the electric field is generated simultaneously with the magnetic field.

10 . The pathogen cell destruction method of claim 6 , wherein the pathogen cell is an oncological cell.

11 . The pathogen cell destruction method of claim 1 , wherein the pathogen cell is an oncological cell.